RESUMO
It is imperative to further the understanding of the drug resistance mechanisms of ovarian cancer (OC) and to identify useful biological markers for prognosis prediction.Cormine, cBioportal, and The Cancer Genome Atlas databases were used to search microarray data of gene methylation related to OC, drug resistance in OC, and prognosis, and to analyze methylated genes potentially inducing the drug resistance in OC. Fifty-five DNA-methylated genes significantly associated with drug resistance in OC were screened, and the regulatory mechanisms underlying changes in methylation levels of these genes were systematically integrated.Enrichment and annotation of biological processes indicated that most of the above DNA-methylated genes were significantly associated with cell proliferation and cell cycle. In addition, pathway enrichment demonstrated that the above DNA-methylated genes were significantly associated with PI3K-AKT and P53 signaling pathways. Among the 55 genes, 4 were significantly associated with OC prognostic disease-free survival, namely bromodomain containing 4, PDZ domain containing 1 (PDZK1), phosphatase and tensin homolog, and TNF receptor superfamily member 10c; 5 were significantly related to overall survival, namely bromodomain containing 4, PDZK1, PIK3C2B, Rh associated glycoprotein, and DYRK; among them, the degree of methylation of TNF receptor superfamily member 10c, PDZK1, and Rh associated glycoprotein genes was significantly correlated with mRNA expression. Furthermore, PDZK1, Rh associated glycoprotein, and TNF receptor superfamily member 10c genes showed significant hypomethylation in drug-resistance tissues of OC, and their mRNAs had significantly high expression.The association between the methylation of these 55 genes and OC and drug resistance in OC, in addition to bioinformatics analyses clarify the important mechanisms of gene methylation in the development, progression, and drug resistance of OC.
Assuntos
Metilação de DNA/genética , Resistencia a Medicamentos Antineoplásicos/genética , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/genética , Big Data , Proliferação de Células , Classe II de Fosfatidilinositol 3-Quinases/genética , Intervalo Livre de Doença , Feminino , Perfilação da Expressão Gênica , Humanos , Estimativa de Kaplan-Meier , Neoplasias Ovarianas/mortalidade , Prognóstico , Análise Serial de Proteínas , Transdução de SinaisRESUMO
Li4Ti5O12 (LTO) as the anode of lithium (Li) ion batteries has high interfacial side reactivity with the electrolyte, which leads to severe gassing behavior and poor cycling stability. Herein, the capacity loss mechanism of the high-tap density LTO microsphere anode under different temperatures (25, 45, and 60 °C) and charge/discharge rates (1 and 5 C) is systematically investigated. The capacity retentions of the LTO/Li cell after 500 cycles at 1 C are 95.6, 90.0, and 87.1% under three temperatures, which drop to 91.9, 58.3, and 20.9% when cycling at 5 C, respectively. Results show that the high temperature and rate almost do not damage the structure of LTO, but greatly affect the thickness and components of the solid electrolyte interface (SEI), and consequently reduce the performance of the LTO/Li cells. An SEI mainly consisting of inorganic species forms on LTO after 500 cycles at 1 C, while organic compounds are observed after 500 cycles at 5 C. The capacity of cycled LTO cannot recover again because of the thick SEI although using new Li metal anodes, separators, and electrolytes. This work demonstrates that it is of great significance for LTO to construct a stable SEI for achieving excellent cycling performance at a high rate and temperature.
